$XFOR .40 - Nasdaq Pharma-On-FIRE-Today! Up 50% after getting 2 BULLISH Analyst recommendations. They have 136 million dollars cash and just released a new product. 1:09 PM EST HC Wainwright & Co. analyst maintains (NASDAQ:XFOR) with a Buy and lowers the price target from $5 to $1.5. Stifel analyst Stephen Willey maintains $XFOR) with a Buy and lowers the price target from $5 to $4.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.